These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31022193)

  • 41. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and Molecular Characterization of Foot and Mouth Disease Viruses from Outbreaks in Some States of Northern Nigeria 2013-2015.
    Ehizibolo DO; Haegeman A; De Vleeschauwer AR; Umoh JU; Kazeem HM; Okolocha EC; Van Borm S; De Clercq K
    Transbound Emerg Dis; 2017 Dec; 64(6):1979-1990. PubMed ID: 28097814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of foot-and-mouth disease virus RNA in pharyngeal epithelium biopsy samples obtained from infected cattle: investigation of possible sites of virus replication and persistence.
    Stenfeldt C; Belsham GJ
    Vet Microbiol; 2012 Jan; 154(3-4):230-9. PubMed ID: 21831538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Within-Host Recombination in the Foot-and-Mouth Disease Virus Genome.
    Ferretti L; Di Nardo A; Singer B; Lasecka-Dykes L; Logan G; Wright CF; Pérez-Martín E; King DP; Tuthill TJ; Ribeca P
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of foot-and-mouth disease virus intra-sample sequence diversity during serial transmission in bovine hosts.
    Morelli MJ; Wright CF; Knowles NJ; Juleff N; Paton DJ; King DP; Haydon DT
    Vet Res; 2013 Mar; 44(1):12. PubMed ID: 23452550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N; Smoliga G; Arzt J
    Vaccine; 2012 Feb; 30(9):1690-701. PubMed ID: 22227230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing.
    Wright CF; Morelli MJ; Thébaud G; Knowles NJ; Herzyk P; Paton DJ; Haydon DT; King DP
    J Virol; 2011 Mar; 85(5):2266-75. PubMed ID: 21159860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle.
    Stenfeldt C; Eschbaumer M; Pacheco JM; Rekant SI; Rodriguez LL; Arzt J
    PLoS One; 2015; 10(11):e0143666. PubMed ID: 26599543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of SAT-2 foot-and-mouth disease virus isolates obtained from cattle during a four-month period in 2001 in Limpopo Province, South Africa.
    Phologane BS; Dwarka RM; Haydon DT; Gerber LJ; Vosloo W
    Onderstepoort J Vet Res; 2008 Dec; 75(4):267-77. PubMed ID: 19294983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Cattle; Tissue-Specific Distribution and Local Cytokine Expression.
    Pacheco JM; Smoliga GR; O'Donnell V; Brito BP; Stenfeldt C; Rodriguez LL; Arzt J
    PLoS One; 2015; 10(5):e0125698. PubMed ID: 25996935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversity and transboundary mobility of serotype O foot-and-mouth disease virus in East Africa: implications for vaccination policies.
    Balinda SN; Sangula AK; Heller R; Muwanika VB; Belsham GJ; Masembe C; Siegismund HR
    Infect Genet Evol; 2010 Oct; 10(7):1058-65. PubMed ID: 20619358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle.
    Höhlich BJ; Wiesmüller KH; Schlapp T; Haas B; Pfaff E; Saalmüller A
    J Virol; 2003 Aug; 77(16):8633-9. PubMed ID: 12885881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recombinant non-structural 3A, 3B and 3AB proteins of foot-and-mouth disease virus: use for differentiation of vaccinated and infected cattle].
    Iakovleva AS; Shcherbakov AV; Kan'shina AV; Mudrak NS; Fomina TA
    Mol Biol (Mosk); 2006; 40(1):165-71. PubMed ID: 16523703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus.
    Jaworski JP; Compaired D; Trotta M; Perez M; Trono K; Fondevila N
    J Virol Methods; 2011 Dec; 178(1-2):191-200. PubMed ID: 21946290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.